Literature DB >> 10460491

Correlation between gender and spontaneous C-cell tumors in the thyroid gland of the Wistar rat.

I Martín-Lacave1, R Bernab, C Sampedro, E Conde, J M Fernández-Santos, M V San Martín, A Beato, H Galera-Davidson.   

Abstract

In many rat strains, C-cell hyperplasia occurs in an age-dependent manner and is often associated with multifocal C-cell carcinoma. The purpose of this study was to investigate the spectrum of spontaneous, proliferative C-cell disorders by gender in Wistar rats throughout their lifespan. The incidence of C-cell hyperplasia shows a significant increase with age (P<0.001) and is much higher in female rats than in male rats (P<0.05). From 3 to 24 months of life, 27.5% of female rats showed a normal C-cell pattern, 55.0% showed C-cell hyperplasia, and 17.5% showed C-cell tumors; while 57.5% of male rats showed a normal C-cell pattern, 32.5% showed C-cell hyperplasia, and 10% showed C-cell tumors. Although the overall frequency of C-cell neoplasms in females was nearly double that in males, these data are not statistically significant. However, the number of C-cell tumors showed a significant increase with age (P<0.05). Therefore, we can conclude that there were significant differences in the incidence of the total spectrum of C-cell proliferative abnormalities in the thyroid gland of Wistar rats that were both age-dependent and gender-dependent.

Entities:  

Mesh:

Year:  1999        PMID: 10460491     DOI: 10.1007/s004410051371

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  8 in total

1.  C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats.

Authors:  Inés Martín-Lacave; María J Borrero; José C Utrilla; José M Fernández-Santos; Manuel de Miguel; Jesús Morillo; Juan M Guerrero; Rocío García-Marín; Esperanza Conde
Journal:  J Anat       Date:  2009-03       Impact factor: 2.610

2.  GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Authors:  Chuqing Cao; Shuting Yang; Zhiguang Zhou
Journal:  Endocrine       Date:  2019-08-16       Impact factor: 3.633

3.  Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).

Authors:  M Angelyn Bethel; Rishi A Patel; Vivian P Thompson; Peter Merrill; Shelby D Reed; Yanhong Li; Sara Ahmadi; Brian G Katona; Stephanie M Gustavson; Peter Ohman; Nayyar Iqbal; Robert F Gagel; Adrian F Hernandez; John B Buse; Rury R Holman
Journal:  Diabetes Care       Date:  2019-04-22       Impact factor: 19.112

Review 4.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

Review 5.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

6.  EXENATIDE TREATMENT REDUCES THYROID GLAND VOLUME, BUT HAS NO EFFECT ON THE SIZE OF THYROID NODULES.

Authors:  D Köseoğlu; Ö Özdemir Başer; D Berker; S Güler
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

7.  Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials.

Authors:  Weiting Hu; Rui Song; Rui Cheng; Caihong Liu; Rui Guo; Wei Tang; Jie Zhang; Qian Zhao; Xing Li; Jing Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

Review 8.  Current Long-Term Pharmacotherapies for the Management of Obesity.

Authors:  Bo-Yeon Kim; Seon Mee Kang; Jee-Hyun Kang; Kyoung Kon Kim; Bomtaeck Kim; Seung Jun Kim; Yang-Hyun Kim; Jung-Hwan Kim; Jae Hyun Kim; Ga Eun Nam; Ji Yeon Park; Jang Won Son; Hye-Jung Shin; Tae Jung Oh; Hyug Lee; Eon-Ju Jeon; Sochung Chung; Yong Hee Hong; Chong Hwa Kim
Journal:  J Obes Metab Syndr       Date:  2020-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.